Discover how stromal cells contribute to therapy resistance in cancer with @FatimaMechta, an internationally recognised leader in tumour heterogeneity.

At #KSStromal26, she will share her insights on CAF-driven immunosuppression in breast cancer.

keysym.us/KSStromal26

🚀 Don’t miss Dr. Michael Briskin, CSO & founding member of Phenomic AI, as he shares how machine learning–powered transcriptomics is driving new drug target discovery in the tumour microenvironment.

Register by 22nd October. keysym.us/KSStromal26 #KSStromal26

We are pleased to host @shouval.bsky.social at #KSStromal26.

Her team studies how tumours reprogram the local microenvironment to enable systematic malignancies. One of the way tumours predominantly do this is by interacting with #fibroblast.

Register now to hear more! keysym.us/KSStromal26

Prof. Tatiana Petrova (University of Lausanne) research focuses on organ- and disease-specific functions of mammalian blood and lymphatic vessels.

We look forward to hearing her speak on how mTORC1 signalling influences lymphatic vessels at #KSStromal26.

Don't miss out - register now!

Prof. Mariapia Degli-Esposti is a leading immunologist whose work has defined the cellular and molecular mechanisms that enable the immune system to protect against pathogens while limiting immunopathology.

We are delighted to have her present at #KSStromal26.

Register now to not miss out!

Immune response in the CNS need to be finely tuned in order to limit excessive inflammation in this delicate and critical organ.

Prof. Dr. Natalia Pikor's (ETH Zurich) research focuses in understanding how fibroblastic stromal cells influences these key processes.

Register now to find out more!

Dr. Ari Molofsky (@arimolofskylab.bsky.social/UCSF) is an MD/PhD with an interest in tissue, stromal and neuro- immunology.

His research focuses on stromal-immune niches across a range of tissue, spanning from the brain to the intestine.

Register now to find out more! Link in bio. #KSStromal26

Dr. Sophie Acton (@actonlab.bsky.social/UCL)

is a Cancer Research UK Senior Fellow with an interest in lymphoid tissue biology.

At #KSStromal26, she'll be sharing her insights on podoplanin - a molecule that controls DC motility within the lymph node.

Register now! Link in bio.

Prof. Sanjiv Luther specialises in uncovering the role of different FRC subsets in a range of immune response settings.

In #KSStromal26, he will be sharing his insights behind fibroblast specialisation.

Wanna hear more? Register now: keysym.us/KSStromal26

We are thrilled to have Dr. Michael Brenner speak about fibroblast inflammation, tissue degradation and fibrosis. He has made many important contributions in understanding RA and will be joining us at #KSStromal26 to talk all things stromal.

Register now!
keysym.us/KSStromal26

Wondering how metastatic #breastcancer patient outcomes can be improved? 🧬

Dr Sheila Stewert (University of Washington), whose research focuses on how age-related #stromal changes drive cancer development, might have the answer.

Register now to hear her insights at #KSStromal26!

Dr. Boris Hinz (@utoronto.ca), Keenan Research Chair in #Fibrosis Research, specialises in studying the role myofibroblast have in pathological tissue repair.

Join us at #KSStromal26 to hear his take on how the mechanical environment shapes stromal activation. 🧫

#immunology #myofibroblast

Thomas Wynn(Pfizer) is an immunologist who specialises in macrophage-mediated #fibrosis and is passionate about developing therapeutics to improve patient's lives.

Register now to hear him share his insights on anti-fibrotic therapeutics #KSStromal26 #stromalimmunology✨